CTNM
ContineumยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CTNM Profile
Contineum Therapeutics, Inc.
A clinical-stage biotechnology company focused on the fields of neurology, inflammation, and immunology.
10578 Science Center Drive, Suite 200 San Diego, California 92121
--
Contineum Therapeutics, Inc., was incorporated in Delaware in 2009 as Versense Pharmaceuticals, Inc. (Versense). In November 2023, the company changed its name to Contineum Therapeutics, Inc. The company is a clinical-stage biopharmaceutical company focused on discovering and developing novel oral small molecule therapies for NI & I indications with high unmet need. They target biological pathways associated with specific clinical injuries that, they believe, once regulated, will significantly alter the course of the disease.
